bromfenac has been researched along with ketorolac in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 13 (54.17) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Ernest, P; Gayton, J; Lehmann, R; Raizman, M; Walters, T | 1 |
| Bucci, FA; Waterbury, LD | 4 |
| Gayton, J | 1 |
| Awh, CC; Busbee, BG; Cleary, TS; Daniel, P; Heier, JS; Stoller, GL; Waterbury, LD | 1 |
| Bahrani, H; Fox, JE; Warren, KA | 1 |
| Attar, M; Borbridge, L; Galindo, D; Hollander, DA; Nguyen, C; Patel, M; Schiffman, RM; Villanueva, L; Waterbury, LD | 1 |
| Kennedy, J; Singer, DD; Wittpenn, JR | 1 |
| Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY | 1 |
| Bom Aggio, F; Bottós, JM; Farah, ME; Rodrigues, EB | 1 |
| Kohnen, T | 1 |
| Bansal, R; Gupta, A; Pandav, SS; Ram, J; Sahu, S | 1 |
| Hess, J; Kauffman, L; Walter, K | 1 |
| Visco, DM | 1 |
| Ding, K; Heath, M; McDonald, MC; Murphy, DA; Riaz, KM; Shah, S; Shah, SV | 1 |
2 review(s) available for bromfenac and ketorolac
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Diclofenac; Humans; Ketorolac; Phenylacetates; Retinal Diseases | 2016 |
9 trial(s) available for bromfenac and ketorolac
| Article | Year |
|---|---|
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2007 |
Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels.
Topics: Absorption; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Double-Blind Method; Female; Humans; Immunoenzyme Techniques; Ketorolac; Male; Mass Spectrometry; Middle Aged; Ophthalmic Solutions; Phacoemulsification | 2008 |
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Female; Humans; Ketorolac; Male; Mass Spectrometry; Middle Aged; Ophthalmic Solutions; Phenylacetates; Retinal Diseases; Tissue Distribution; Vitrectomy; Vitreous Body | 2009 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2011 |
Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates | 2011 |
Topical NSAIDs effect on corneal sensitivity.
Topics: Administration, Topical; Adult; Analgesia; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cornea; Diclofenac; Female; Humans; Ketorolac; Male; Ophthalmic Solutions; Phenylacetates; Sensation | 2015 |
The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Female; Humans; Inflammation; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Miosis; Phacoemulsification; Postoperative Complications; Postoperative Period; Premedication; Treatment Outcome | 2015 |
Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Female; Humans; Intraocular Pressure; Ketorolac; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Photometry; Postoperative Complications; Prospective Studies; Visual Acuity | 2015 |
13 other study(ies) available for bromfenac and ketorolac
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Ketorolac; Phenylacetates | 2008 |
Concentration and dosing of ketorolac versus bromfenac.
Topics: Absorption; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Humans; Immunoenzyme Techniques; Ketorolac; Mass Spectrometry; Ophthalmic Solutions; Phacoemulsification | 2009 |
Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Dextrans; Dinoprostone; Endophthalmitis; Eye; Female; Fluorescein-5-isothiocyanate; Ketorolac; Lipopolysaccharides; Prostaglandin-Endoperoxide Synthases; Rabbits | 2011 |
Treating inflammation after lens surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Humans; Ketorolac; Phacoemulsification; Phenylacetates; Postoperative Complications | 2015 |
Rate of pseudophakic cystoid macular edema using intraoperative and topical nonsteroidal antiinflammatory drugs alone without steroids.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Female; Humans; Intraoperative Care; Ketorolac; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylephrine; Postoperative Care; Postoperative Complications; Pseudophakia; Retrospective Studies; Visual Acuity | 2020 |
Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Dexamethasone; Humans; Incidence; Iritis; Ketorolac; Macular Edema; Pain; Photophobia; Postoperative Complications; Retrospective Studies | 2023 |
Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Costs and Cost Analysis; Diclofenac; Humans; Ketorolac; Ophthalmic Solutions; Prospective Studies | 2023 |